HK Stock MarketDetailed Quotes

WUXI BIO (02269)

Watchlist

39.780
-0.240-0.60%

Market Closed Jan 16 16:07 CST

164.43BMarket Cap35.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

WUXI BIO (02269) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

16.08%9.95B

9.63%18.68B

0.97%8.57B

11.56%17.03B

17.84%8.49B

48.38%15.27B

63.53%7.21B

83.35%10.29B

126.67%4.41B

40.88%5.61B

Operating income

16.08%9.95B

9.63%18.68B

0.97%8.57B

11.56%17.03B

17.84%8.49B

48.38%15.27B

63.53%7.21B

83.35%10.29B

126.67%4.41B

40.88%5.61B

Cost of sales

-9.11%-5.7B

-8.02%-11.02B

-5.94%-5.22B

-19.45%-10.21B

-30.01%-4.93B

-56.46%-8.54B

-79.78%-3.79B

-77.34%-5.46B

-82.39%-2.11B

-32.46%-3.08B

Operating expenses

-9.11%-5.7B

-8.02%-11.02B

-5.94%-5.22B

-19.45%-10.21B

-30.01%-4.93B

-56.46%-8.54B

-79.78%-3.79B

-77.34%-5.46B

-82.39%-2.11B

-32.46%-3.08B

Gross profit

26.95%4.25B

12.05%7.65B

-5.92%3.35B

1.55%6.83B

4.32%3.56B

39.25%6.72B

48.60%3.41B

90.64%4.83B

191.73%2.3B

52.70%2.53B

Selling expenses

-21.09%-270.11M

-61.08%-473.6M

-111.65%-223.06M

-80.47%-294.01M

-57.06%-105.39M

-30.70%-162.91M

-11.18%-67.1M

-32.02%-124.65M

-24.55%-60.36M

-22.49%-94.42M

Administrative expenses

-1.05%-781.13M

-11.91%-1.67B

-13.73%-772.99M

-17.78%-1.5B

-30.67%-679.64M

-44.94%-1.27B

-49.61%-520.11M

-71.27%-875.93M

-70.93%-347.64M

-39.25%-511.44M

Research and development expenses

0.16%-343.51M

2.47%-766.44M

-0.77%-344.06M

-15.09%-785.82M

-25.93%-341.44M

-36.13%-682.82M

-135.00%-271.13M

-65.14%-501.58M

7.27%-115.38M

-16.98%-303.73M

Impairment and provision

29.62%-133.84M

52.56%-151.78M

-44.29%-190.17M

-23.77%-319.97M

-86.05%-131.8M

-65.02%-258.53M

46.80%-70.84M

-29.41%-156.67M

-135.33%-133.17M

-1,669.39%-121.06M

-Other impairment is provision

29.62%-133.84M

52.56%-151.78M

-44.29%-190.17M

-23.77%-319.97M

-86.05%-131.8M

-65.02%-258.53M

46.80%-70.84M

-29.41%-156.67M

-135.33%-133.17M

-1,669.39%-121.06M

Special items of operating profit

167.70%687.39M

1.74%406.5M

-15.93%256.78M

-62.73%399.54M

-34.84%305.43M

24.33%1.07B

6.83%468.77M

71.24%862.24M

17.28%438.81M

150.03%503.54M

Operating profit

64.30%3.41B

15.23%4.99B

-20.38%2.08B

-20.10%4.33B

-11.68%2.61B

34.47%5.42B

42.02%2.95B

101.03%4.03B

185.35%2.08B

74.52%2.01B

Financing cost

-22.72%-83.54M

0.57%-157.59M

13.63%-68.07M

-146.17%-158.49M

-247.82%-78.82M

-64.28%-64.38M

-8.56%-22.66M

8.29%-39.19M

6.83%-20.87M

-117.96%-42.73M

Share of profits of associates

----

184.39%2.63M

Earning before tax

65.71%3.33B

15.83%4.83B

-20.59%2.01B

-22.10%4.17B

-13.69%2.53B

34.18%5.36B

42.36%2.93B

103.13%3.99B

191.90%2.06B

74.48%1.97B

Tax

-150.58%-571.49M

-47.39%-889.03M

-19.33%-228.07M

25.34%-603.18M

38.13%-191.12M

-66.73%-807.87M

-76.07%-308.91M

-77.44%-484.54M

-785.41%-175.45M

-134.80%-273.07M

After-tax profit from continuing operations

54.84%2.76B

10.50%3.95B

-23.85%1.78B

-21.52%3.57B

-10.81%2.34B

29.68%4.55B

39.22%2.62B

107.28%3.51B

157.67%1.88B

67.54%1.69B

Earning after tax

54.84%2.76B

10.50%3.95B

-23.85%1.78B

-21.52%3.57B

-10.81%2.34B

29.68%4.55B

39.22%2.62B

107.28%3.51B

157.67%1.88B

67.54%1.69B

Minority profit

48.40%417.35M

244.83%589.29M

295.07%281.23M

31.84%170.9M

-17.38%71.19M

7.92%129.62M

112.02%86.16M

3,053.97%120.1M

851.30%40.64M

209.80%3.81M

Profit attributable to shareholders

56.05%2.34B

-1.28%3.36B

-33.86%1.5B

-23.09%3.4B

-10.59%2.27B

30.45%4.42B

37.62%2.54B

100.63%3.39B

150.25%1.84B

66.59%1.69B

Basic earnings per share

56.76%0.58

0.00%0.82

-32.73%0.37

-22.64%0.82

-9.84%0.55

30.86%1.06

38.64%0.61

88.37%0.81

131.58%0.44

59.26%0.43

Diluted earnings per share

57.14%0.55

1.30%0.78

-32.69%0.35

-23.76%0.77

-10.34%0.52

31.17%1.01

38.10%0.58

92.50%0.77

133.33%0.42

60.00%0.4

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Deloitte Guan Huang Chen Fang Certified Public Accountants

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	16.08%9.95B	9.63%18.68B	0.97%8.57B	11.56%17.03B	17.84%8.49B	48.38%15.27B	63.53%7.21B	83.35%10.29B	126.67%4.41B	40.88%5.61B
Operating income	16.08%9.95B	9.63%18.68B	0.97%8.57B	11.56%17.03B	17.84%8.49B	48.38%15.27B	63.53%7.21B	83.35%10.29B	126.67%4.41B	40.88%5.61B
Cost of sales	-9.11%-5.7B	-8.02%-11.02B	-5.94%-5.22B	-19.45%-10.21B	-30.01%-4.93B	-56.46%-8.54B	-79.78%-3.79B	-77.34%-5.46B	-82.39%-2.11B	-32.46%-3.08B
Operating expenses	-9.11%-5.7B	-8.02%-11.02B	-5.94%-5.22B	-19.45%-10.21B	-30.01%-4.93B	-56.46%-8.54B	-79.78%-3.79B	-77.34%-5.46B	-82.39%-2.11B	-32.46%-3.08B
Gross profit	26.95%4.25B	12.05%7.65B	-5.92%3.35B	1.55%6.83B	4.32%3.56B	39.25%6.72B	48.60%3.41B	90.64%4.83B	191.73%2.3B	52.70%2.53B
Selling expenses	-21.09%-270.11M	-61.08%-473.6M	-111.65%-223.06M	-80.47%-294.01M	-57.06%-105.39M	-30.70%-162.91M	-11.18%-67.1M	-32.02%-124.65M	-24.55%-60.36M	-22.49%-94.42M
Administrative expenses	-1.05%-781.13M	-11.91%-1.67B	-13.73%-772.99M	-17.78%-1.5B	-30.67%-679.64M	-44.94%-1.27B	-49.61%-520.11M	-71.27%-875.93M	-70.93%-347.64M	-39.25%-511.44M
Research and development expenses	0.16%-343.51M	2.47%-766.44M	-0.77%-344.06M	-15.09%-785.82M	-25.93%-341.44M	-36.13%-682.82M	-135.00%-271.13M	-65.14%-501.58M	7.27%-115.38M	-16.98%-303.73M
Impairment and provision	29.62%-133.84M	52.56%-151.78M	-44.29%-190.17M	-23.77%-319.97M	-86.05%-131.8M	-65.02%-258.53M	46.80%-70.84M	-29.41%-156.67M	-135.33%-133.17M	-1,669.39%-121.06M
-Other impairment is provision	29.62%-133.84M	52.56%-151.78M	-44.29%-190.17M	-23.77%-319.97M	-86.05%-131.8M	-65.02%-258.53M	46.80%-70.84M	-29.41%-156.67M	-135.33%-133.17M	-1,669.39%-121.06M
Special items of operating profit	167.70%687.39M	1.74%406.5M	-15.93%256.78M	-62.73%399.54M	-34.84%305.43M	24.33%1.07B	6.83%468.77M	71.24%862.24M	17.28%438.81M	150.03%503.54M
Operating profit	64.30%3.41B	15.23%4.99B	-20.38%2.08B	-20.10%4.33B	-11.68%2.61B	34.47%5.42B	42.02%2.95B	101.03%4.03B	185.35%2.08B	74.52%2.01B
Financing cost	-22.72%-83.54M	0.57%-157.59M	13.63%-68.07M	-146.17%-158.49M	-247.82%-78.82M	-64.28%-64.38M	-8.56%-22.66M	8.29%-39.19M	6.83%-20.87M	-117.96%-42.73M
Share of profits of associates	----	----	----	----	----	----	----	----	----	184.39%2.63M
Earning before tax	65.71%3.33B	15.83%4.83B	-20.59%2.01B	-22.10%4.17B	-13.69%2.53B	34.18%5.36B	42.36%2.93B	103.13%3.99B	191.90%2.06B	74.48%1.97B
Tax	-150.58%-571.49M	-47.39%-889.03M	-19.33%-228.07M	25.34%-603.18M	38.13%-191.12M	-66.73%-807.87M	-76.07%-308.91M	-77.44%-484.54M	-785.41%-175.45M	-134.80%-273.07M
After-tax profit from continuing operations	54.84%2.76B	10.50%3.95B	-23.85%1.78B	-21.52%3.57B	-10.81%2.34B	29.68%4.55B	39.22%2.62B	107.28%3.51B	157.67%1.88B	67.54%1.69B
Earning after tax	54.84%2.76B	10.50%3.95B	-23.85%1.78B	-21.52%3.57B	-10.81%2.34B	29.68%4.55B	39.22%2.62B	107.28%3.51B	157.67%1.88B	67.54%1.69B
Minority profit	48.40%417.35M	244.83%589.29M	295.07%281.23M	31.84%170.9M	-17.38%71.19M	7.92%129.62M	112.02%86.16M	3,053.97%120.1M	851.30%40.64M	209.80%3.81M
Profit attributable to shareholders	56.05%2.34B	-1.28%3.36B	-33.86%1.5B	-23.09%3.4B	-10.59%2.27B	30.45%4.42B	37.62%2.54B	100.63%3.39B	150.25%1.84B	66.59%1.69B
Basic earnings per share	56.76%0.58	0.00%0.82	-32.73%0.37	-22.64%0.82	-9.84%0.55	30.86%1.06	38.64%0.61	88.37%0.81	131.58%0.44	59.26%0.43
Diluted earnings per share	57.14%0.55	1.30%0.78	-32.69%0.35	-23.76%0.77	-10.34%0.52	31.17%1.01	38.10%0.58	92.50%0.77	133.33%0.42	60.00%0.4
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants	--	Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?